LENSAR Inc. - רווח נקי למניה בארבעת הרבעונים האחרונים LNSR

The implementation rates of LENSAR, Inc. (LNSR) systems are being constrained by a shortage of clinic funding, while high R&D costs are pushing back the break-even point. LENSAR, Inc. (LNSR) develops robotic cataract surgery systems that require physician oversight. This chart shows EPS at 126.90, confirming FCF resilience driven by per-procedure licensing fees and the expansion of the installed equipment base.
LENSAR Inc. - פילוחים אנליטיים ומדדי מפתח (LNSR)

LENSAR, Inc. (LNSR) maintains technological superiority in AI visualization for ALLY surgery, which necessitates constant profitability control. By analyzing the TTM net income per share annual trend, an investor can observe the percentage change in EPS over a rolling year. This metric smooths out quarterly volatility by comparing current earnings with the same period from the previous year. Steady growth of this indicator confirms the effectiveness of R&D investments and the resilience of the business model.